Søren Knud Carlsen
Director/Board Member at Tekniikan Akatemia -säätiö sr
Søren Knud Carlsen active positions
Companies | Position | Start | End |
---|---|---|---|
Tekniikan Akatemia -säätiö sr
Tekniikan Akatemia -säätiö sr Investment Trusts/Mutual FundsMiscellaneous Tekniikan Akatemia -säätiö sr, also known as Technology Academy Finland (TAF), is based in Helsinki, Finland. The CEOs of the Finnish company are Mikko Salaspuro and Ainomaija Susanna Haarla. TAF awards the €1 million Millennium Technology Prize and organizes associated events and initiatives. The private company provides an international meeting ground for corporate life, academia, and policymakers, and promotes Finland's position in the community. The Millennium Technology Prize is the world's most prestigious award for breakthrough innovations that improve the quality of people's lives. | Director/Board Member | - | - |
Biosyntia ApS
Biosyntia ApS BiotechnologyHealth Technology Biosyntia ApS provides services in synthetic biology and metabolic engineering fields. It offers biocatalysts for fermentation of fine chemicals. The company was founded by Andreas Hougaard Laustsen, Morten Otto Alexander Sommer, and Hans Jasper Genee in 2012 and is headquartered in Copenhagen, Denmark. | Director/Board Member | - | - |
Bioneer A/S
Bioneer A/S Pharmaceuticals: MajorHealth Technology Bioneer A/S develops and manufactures drugs. The firm's products and services drug development, molecular histology, dynamic gastric model, biomarkers and drug targets, protein manufacturing, mammalian cell technology, immune targeting, active ingredients and microorganisms. The company was founded in 2003 and is headquartered in Horsholm, Denmark. | Director/Board Member | - | - |
Career history of Søren Knud Carlsen
Former positions of Søren Knud Carlsen
Companies | Position | Start | End |
---|---|---|---|
CHRISTIAN HANSEN | Director/Board Member | 01/11/2012 | 01/01/2016 |
Independent Dir/Board Member | 01/11/2012 | 01/01/2016 | |
Novo Ventures 1 A/S
Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Director of Investments | 01/04/2000 | 31/08/2015 |
Corporate Officer/Principal | 01/04/2000 | 31/08/2015 | |
Novo Seeds
Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Private Equity Investor | 10/08/2009 | 31/08/2015 |
Corporate Officer/Principal | 10/08/2009 | 31/08/2015 | |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Director/Board Member | - | 02/09/2014 |
PTC THERAPEUTICS, INC. | Director/Board Member | 01/08/2001 | 07/03/2013 |
Novo Holdings AS (Denmark)
Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Corporate Officer/Principal | - | - |
░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Training of Søren Knud Carlsen
Technical University of Denmark | Graduate Degree |
Statistics
International
Denmark | 10 |
United States | 2 |
Finland | 2 |
Operational
Director/Board Member | 7 |
Corporate Officer/Principal | 3 |
Director of Investments | 1 |
Sectoral
Health Technology | 6 |
Finance | 4 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
PTC THERAPEUTICS, INC. | Health Technology |
Private companies | 9 |
---|---|
Novo Ventures 1 A/S
Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Finance |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Health Technology |
7TM A/S
7TM A/S Pharmaceuticals: MajorHealth Technology 7TM A/S performs research and development within biotechnology. It engages in clinical development of drugs focusing on obesity and gastrointestinal diseases. The company was founded by Thue Walter Schwartz, Anders Fink Vadsholt, Mette Kirstine Agger, Christian Ellebæk Elling, and Peter Moldt on January 1, 2000 and is headquartered in Hørsholm, Denmark. | Health Technology |
Novo Seeds
Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Finance |
Chr. Hansen Holding A/S
Chr. Hansen Holding A/S Food: Specialty/CandyConsumer Non-Durables Chr. Hansen Holding A/S is a bioscience company engaged in the development of natural solutions for the food, nutritional, pharmaceutical, and agricultural industries. It operates through the following segments: Food Cultures & Enzymes and Health & Nutrition. The Food Cultures & Enzymes segment is focused on producing and selling the cultures, enzymes, and probiotic products that help determine the taste, flavor, texture, shelf life, nutritional value, and health benefits of consumer products in the food industry. The Health & Nutrition segment is involved in the manufacturing and distribution of products for the dietary supplement, over-the-counter pharmaceutical, infant formula, animal feed, and plant protection industries. The company was founded by Christian Ditlev Ammentorp Hansen in 1874 and is headquartered in Horsholm, Denmark. | Consumer Non-Durables |
Tekniikan Akatemia -säätiö sr
Tekniikan Akatemia -säätiö sr Investment Trusts/Mutual FundsMiscellaneous Tekniikan Akatemia -säätiö sr, also known as Technology Academy Finland (TAF), is based in Helsinki, Finland. The CEOs of the Finnish company are Mikko Salaspuro and Ainomaija Susanna Haarla. TAF awards the €1 million Millennium Technology Prize and organizes associated events and initiatives. The private company provides an international meeting ground for corporate life, academia, and policymakers, and promotes Finland's position in the community. The Millennium Technology Prize is the world's most prestigious award for breakthrough innovations that improve the quality of people's lives. | Miscellaneous |
Novo Holdings AS (Denmark)
Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Finance |
Biosyntia ApS
Biosyntia ApS BiotechnologyHealth Technology Biosyntia ApS provides services in synthetic biology and metabolic engineering fields. It offers biocatalysts for fermentation of fine chemicals. The company was founded by Andreas Hougaard Laustsen, Morten Otto Alexander Sommer, and Hans Jasper Genee in 2012 and is headquartered in Copenhagen, Denmark. | Health Technology |
Bioneer A/S
Bioneer A/S Pharmaceuticals: MajorHealth Technology Bioneer A/S develops and manufactures drugs. The firm's products and services drug development, molecular histology, dynamic gastric model, biomarkers and drug targets, protein manufacturing, mammalian cell technology, immune targeting, active ingredients and microorganisms. The company was founded in 2003 and is headquartered in Horsholm, Denmark. | Health Technology |
- Stock Market
- Insiders
- Søren Knud Carlsen
- Experience